Larvol Delta - A-Study-to-Investigate-the-Safety-and-Efficacy-of-TEG002-in-RelapsedRefractory-Multiple-Myeloma-Patients

GDT002 - Gadeta

http://clinicaltrials.gov/ct2/show/NCT04688853

Sep 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next